Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Chugai Pharmaceutical Co Ltd
(CHGCF)
OTHER OTC
:CHGCF
CHGCF
Chugai Pharmaceutical Co
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Chugai Pharmaceutical Co (CHGCF) Stock News & Sentiment
AI Analyst Report
Follow
21
Followers
Premium
Company Announcements
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
8d ago
Premium
Company Announcements
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
14d ago
Premium
Company Announcements
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
17d ago
Premium
Company Announcements
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
28d ago
CHGCF
Premium
Company Announcements
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
30d ago
CHGCF
Premium
Company Announcements
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
30d ago
CHGCF
Premium
Company Announcements
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
2M ago
More CHGCF News >
CHGCF News on the Web
All News
Bearish News
Bullish News
2026-04-06
Jefferies Sticks to Its Hold Rating for Chugai Pharmaceutical Co (CHGCF)
TipRanks News
Neutral
2026-04-01
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
TipRanks News
Neutral
2026-03-26
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
TipRanks News
Bullish
2026-03-23
Macquarie Sticks to Its Buy Rating for Chugai Pharmaceutical Co (CHGCF)
TipRanks News
Bullish
2026-03-12
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
TipRanks News
Bullish
2026-03-12
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
2026-03-10
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
TipRanks News
Bullish
2026-03-10
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
TipRanks News
Neutral
38
Results | Showing
1
out of
5
News Score - Last 7 Days
Neutral
CHGCF
Sector Average
Media Buzz
This Week
1 articles
Weekly Average
1.5 articles
News Sentiment
This Week
50%
Sector Average
66%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is CHGCF’s Media Buzz Sentiment?
1 articles about CHGCF were published this week. In an average week, 1.5 articles are published.
What is CHGCF’s weekly average amount of articles?
In an average week, 1.5 articles about CHGCF are published.
What is CHGCF’s News Sentiment?
50% of articles about CHGCF were positive this week, compared to its sector average of 66%.
Healthcare Stocks that are Trending in the News
VCEL
Vericel
NBIX
Neurocrine
ANGO
AngioDynamics
ORGO
Organogenesis Holdings
UNH
UnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.